Pharmaceutical Quality Assurance: Current Practices and Future Trends
Abstract
Aim: This article aims to explore current practices and fu-ture trends in pharmaceutical quality assurance, highlighting the importance of high-quality products within global regula-tory frameworks. Methods: A comprehensive literature review was conduct-ed, analyzing 102 relevant papers that discuss various quality management practices and regulatory guidelines in the pharma-ceutical industry. Results: The findings indicate that frameworks such as the FDA’s current Good Manufacturing Practices (cGMP), WHO guidelines, and EU regulations significantly enhance drug safe-ty and efficacy. Additionally, initiatives like Quality by Design (QbD), Total Quality Management (TQM), and lean manufac-turing principles have emerged as vital components for proac-tive quality assurance, focusing on continuous improvement. Conclusion: The pharmaceutical industry is shifting to-wards an integrated quality management approach that empha-sizes risk management, corrective actions, and customer sat-isfaction. Embracing these trends will enable organizations to better navigate regulatory complexities and enhance the overall quality of pharmaceutical products